Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

tumor necrosis factor receptor superfamily, member 10a, Mouse, Polyclonal Antibody, Abnova™

Mouse polyclonal antibody raised against a partial recombinant TNFRSF10A.

Supplier:  Abnova Corporation H00008797A02

Catalog No. 89-004-403


Only null left
Add to Cart

Description

Description

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is activated by tumor necrosis factor-related apoptosis inducing ligand (TNFSF10/TRAIL), and thus transduces cell death signal and induces cell apoptosis. Studies with FADD-deficient mice suggested that FADD, a death domain containing adaptor protein, is required for the apoptosis mediated by this protein. [provided by RefSeq

Sequence: PSSAATIKLHDQSIGTQQWEHSPLGELCPPGSHRSERPGACNRCTEGVGYTNASNNLFACLPCTACKSDEEERSPCTTTRNTACQCKPGTFRNDNSAEMC
Specifications

Specifications

tumor necrosis factor receptor superfamily, member 10a
Polyclonal
Mouse polyclonal antibody raised against a partial recombinant TNFRSF10A.
TNFRSF10A
APO2/CD261/DR4/MGC9365/TRAILR-1/TRAILR1
Mouse
50 μL
Apoptosis
Primary
Human
Serum
ELISA, Western Blot
Unconjugated
50% glycerol
BC012866
TNFRSF10A
TNFRSF10A (AAH12866, 105 a.a. ∼ 204 a.a) partial recombinant protein with GST tag.
RUO
Yes
8797
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.